Skip to content

Treatment of supraventricular tachycardia with Cryo-Ablation under ICE (intracardiac echocardiography) navigation

Treatment of supraventricular tachycardia with Cryo-Ablation under ICE (intracardiac echocardiography) navigation - ICE-SVT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011360
Enrollment
50
Registered
2016-12-14
Start date
2016-10-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I47.1

Interventions

Group 1: Catheterablation under fluoroscopic control is the first choise treatment of supraventricular tachycardias. We'd like to investigate the combination of intravscular echocardiography (ICE) Nav

Sponsors

Universitätsklinikum Magdeburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: documented or clinical probably supraventricular tachycardia

Exclusion criteria

Exclusion criteria: documented or clinical probably ventricular tachycardia, atrial fibrillation, atrial flutter, fever, acute infection, acute or subacute leg vein thrombosis or pulmonary embolism, pregnancy

Design outcomes

Primary

MeasureTime frame
The aim of the study is to observe and analyse the fluoroscopic time and radiation dose (both parameters are routinely documented for every electrophysiologic study) during Cryothermal-ablation of atrio-ventricular-node-reentry-tachycardia under intracardiac-echocardiography-Navigation.

Secondary

MeasureTime frame
Secondary endpoint of the study is to assess and analyse the success rate of the cryothermal-ablation for treatment of atrioventricular-node-reentry-tachycardia under intracardiac-echocardiography-Navigation. Success is defined as clinical freedom from arrhythmia after 3 and 12 months.

Countries

Germany

Contacts

Public ContactBlerim Luani

Universitätsklinikum MagdeburgKlinik für Kardiologie und Angiologie

blerim.luani@med.ovgu.de0391 67 15 206

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 2, 2026